|
RNF13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.964990E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.602540E-03 |
| Normal-vs-Stage2 |
8.292400E-02 |
| Normal-vs-Stage3 |
1.520800E-01 |
| Normal-vs-Stage4 |
4.557500E-02 |
| Stage1-vs-Stage2 |
5.175200E-01 |
| Stage1-vs-Stage3 |
4.036600E-04 |
| Stage1-vs-Stage4 |
4.14990000000559E-05 |
| Stage2-vs-Stage3 |
2.229900E-02 |
| Stage2-vs-Stage4 |
1.098480E-02 |
| Stage3-vs-Stage4 |
6.546200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.368200E-01 |
| Normal-vs-AfricanAmerican |
7.134400E-01 |
| Normal-vs-Asian |
4.773200E-01 |
| Caucasian-vs-AfricanAmerican |
8.124800E-01 |
| Caucasian-vs-Asian |
4.812000E-01 |
| AfricanAmerican-vs-Asian |
4.184800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.921400E-01 |
| Normal-vs-Female |
2.893900E-02 |
| Male-vs-Female |
7.990400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.398800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.562630E-01 |
| Normal-vs-Age(61-80Yrs) |
5.448800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.662400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.759600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.425600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.611400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.030800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.024400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.910000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.749670E-02 |
| Normal-vs-Grade 2 |
8.215600E-04 |
| Normal-vs-Grade 3 |
8.021400E-01 |
| Normal-vs-Grade 4 |
2.32759999996279E-06 |
| Grade 1-vs-Grade 2 |
4.251600E-01 |
| Grade 1-vs-Grade 3 |
1.964440E-02 |
| Grade 1-vs-Grade 4 |
1.74157999999203E-05 |
| Grade 2-vs-Grade 3 |
2.703300E-03 |
| Grade 2-vs-Grade 4 |
7.36110061794193E-11 |
| Grade 3-vs-Grade 4 |
1.80630000001791E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.98600000006688E-07 |
| Normal-vs-ccB subtype |
1.909210E-01 |
| ccA subtype-vs-ccB subtype |
7.00179999535422E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.227500E-02 |
| Normal-vs-N1 |
4.031800E-01 |
| N0-vs-N1 |
2.191000E-01 |
|
|
